Articles dans des revues avec comité de lecture (396)
  1. 49. El Hachem, G., Gombos, A., & Awada, A. (2019). Recent advances in understanding breast cancer and emerging therapies with a focus on luminal and triple-negative breast cancer. F1000Research, 8. doi:10.12688/f1000research.17542.1
  2. 50. Haltout, J., Awada, A., Paesmans, M., Moreau, M., Klastersky, J., Machiels, G., Ignatiadis, M., & Kotecki, N. (2019). Predictive factors for cancer-associated thrombosis in a large retrospective single-center study. Supportive care in cancer. doi:10.1007/s00520-018-4602-6
  3. 51. Afani, L., Errihani, H., & Awada, A. (2019). Prise en charge thérapeutique des paragangliomes malins: Revue de littérature à travers un cas illustratif. The Pan African medical journal, 32, 62. doi:10.11604/pamj.2019.32.62.8812
  4. 52. Flament, A., Hendlisz, A., Shaza, L., Aspeslagh, S., Vouche, M., Donckier De Donceel, V., Awada, A., Machiels, J. P., Van Den Eynde, M., Canon, J.-L., Carrasco, J., Lonez, C., & Lehmann, F. (2018). Phase I studies assessing the safety and clinical activity of multiple doses of a NKG2D-based CAR-T therapy, CYAD-01, in metastatic colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 29, viii203. doi:10.1093/annonc/mdy281.157
  5. 53. Maurer, C., Tulpin, L., Moreau, M., Dumitrescu, C., de Azambuja, E., Paesmans, M., Nogaret, J.-M., Piccart-Gebhart, M., & Awada, A. (2018). Risk factors for the development of brain metastases in patients with HER2-positive breast cancer. ESMO Open, 3(6), e0004. doi:10.1136/esmoopen-2018-000440
  6. 54. Kotecki, N., & Awada, A. (2018). Tackling the challenges of brain metastases in solid tumors. Current opinion in oncology, 30(5), 330-331. doi:10.1097/CCO.0000000000000472
  7. 55. Sidibe, F. M., Traore, Z., Georgala, A., Kanab, R., Larsimont, D., Awada, A., & Piccart-Gebhart, M. (2018). Carcinome à petite cellule de l'endomètre : étude clinicopathologique et prise en charge de trois cas. Bulletin du cancer, 105(9), 842-846. doi:10.1016/j.bulcan.2018.06.007
  8. 56. Krayem, M., Najem, A., Journé, F., Morandini, R., Sales, F., Awada, A., & Ghanem, G. E. (2018). Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma. Oncotarget, 9(61), 31888-31903. doi:10.18632/oncotarget.25879
  9. 57. Rugo, H. H., Cortes, J., Awada, A., O'Shaughnessy, J., Twelves, C., Im, S. –., Hannah, A. L., Lu, L., Sy, S., Caygill, K., Zajchowski, D. D., Davis, D. D., Tagliaferri, M., Hoch, U., & Perez, E. A. (2018). Change in Topoisomerase 1-Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol. Clinical cancer research, 24(14), 3348-3357. doi:10.1158/1078-0432.CCR-17-3059
  10. 58. de Hemptinne, Q., Picard, F. A., Briki, R., Awada, A., Silance, P.-G., Dolatabadi, D., Debbas, N., & Unger, P. (2018). Drug-Eluting Resorbable Magnesium Scaffold Implantation in ST-Segment Elevation Myocardial Infarction: A Pilot Study. The Journal of invasive cardiology, 30(6), 202-206.
  11. 59. El Hachem, G., Jungels, C., Larsimont, D., & Awada, A. (2018). Une tumeur mullérienne mixte maligne rétropéritonéale de localisation et pronostic exceptionnels. Revue médicale de Bruxelles, 39(3), 146-149. doi:10.30637/2018.17-072
  12. 60. Awada, A., De Cannière, D., Silance, P.-G., & Unger, P. (2018). Echocardiographic demonstration of a thrombus straddling the patent foramen ovale and pulmonary embolism. European heart journal. Cardiovascular imaging, 19(3), 358. doi:10.1093/ehjci/jex256
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 Suivant >>